Development of ONCR-177, an armed oncolytic HSV-1 designed for potent and systemic stimulation of antitumor immunity
Wednesday, October 21, 2020 7:10 AM to 7:40 AM · 30 min. (Africa/Abidjan)
Immuno-Oncology
Vibalogics GmbH
World Vaccine & Immunotherapy Congress West Coast
Log in
See all the content and easy-to-use features by logging in
Continue as a guest
Log in
Continue as a guest
Terrapinn UK
World Vaccine Congress Europe
Log in
Language
Organizing events?
Resource center
Contact app support
Legal notice
Terms of Use
Privacy Policy
Cookies Policy
Cookies consent
Home
Full Conference Agenda
